REGULATORY
MHLW Orders Label Revisions for Dexamethasone, Betamethasone to Warn of Phaeochromocytoma Crisis
The Ministry of Health, Labor and Welfare (MHLW) on May 13 ordered label revisions for drugs containing dexamethasone- or betamethasone-related steroids, calling for the addition of a warning regarding the risk of phaeochromocytoma crisis in patients taking these medicines. The…
To read the full story
Related Article
- PMDA Reviewing Safety Risks for Dexamethasone, Teicoplanin
March 28, 2022
REGULATORY
- Japan Panel OKs Carvykti’s Earlier Use in Multiple Myeloma
June 30, 2026
- Govt to Explore Greater Rewards for Innovative Drugs in Honebuto
June 29, 2026
- MHLW Starts Technical Review of OTC-Like Drug Charge Exemptions
June 29, 2026
- Takeda to Shift Immunoglobulin Production to 10% Formulation
June 29, 2026
- Japan’s Immunoglobulin Self-Sufficiency Rate Falls Below 60%
June 29, 2026
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…





